{"transactions":[{"id":4639975,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":23803,"kind":"person","name":"Cook Meredith","position":1,"cik":"0001938861","reported_name":"Cook Meredith","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SR. VP, GENERAL COUNSEL & SEC."}}],"security":"Common Stock","published_at":"2026-10-14T00:47:42.000Z","date":"2026-10-13","kind":"sale","planned":true,"acquired":false,"shares":500,"price":73.59,"value":36795.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2025."}],"balance_after":73424,"source":{"system":"sec-edgar","filing":"0001938861-26-000028","document":"wk-form4_1791938859.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1938861/000193886126000028/wk-form4_1791938859.xml","form_type":"4"}},{"id":4633299,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":18119,"kind":"person","name":"CAREY STEPHEN P.","position":1,"cik":"0001674236","reported_name":"CAREY STEPHEN P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & CFO"}}],"security":"Common Stock","published_at":"2026-09-30T20:52:15.000Z","date":"2026-09-29","kind":"sale","planned":true,"acquired":false,"shares":2850,"price":73,"value":208050.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 6, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares were sold in multiple trades at prices ranging from $72.57 to $73.86. The price reported above reflects the weighted average sales price."}],"balance_after":168993,"source":{"system":"sec-edgar","filing":"0001674236-26-000024","document":"wk-form4_1790801532.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000167423626000024/wk-form4_1790801532.xml","form_type":"4"}},{"id":4619334,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":19644,"kind":"person","name":"Lalwani Nikhil","position":1,"cik":"0001822629","reported_name":"Lalwani Nikhil","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT & CEO"}}],"security":"Common Stock","published_at":"2026-09-16T20:20:52.000Z","date":"2026-09-15","kind":"sale","planned":true,"acquired":false,"shares":5400,"price":71,"value":383400.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 26, 2026."}],"balance_after":339089,"source":{"system":"sec-edgar","filing":"0001822629-26-000016","document":"wk-form4_1789590049.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1822629/000182262926000016/wk-form4_1789590049.xml","form_type":"4"}},{"id":4617584,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":39807,"kind":"person","name":"Thoma Jeanne","position":1,"cik":"0001819879","reported_name":"Thoma Jeanne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-09-15T00:57:19.000Z","date":"2026-09-11","kind":"sale","planned":true,"acquired":false,"shares":1000,"price":71.53,"value":71530.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 12, 2026."}],"balance_after":26762,"source":{"system":"sec-edgar","filing":"0001819879-26-000006","document":"wk-form4_1789433836.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819879/000181987926000006/wk-form4_1789433836.xml","form_type":"4"}},{"id":4617583,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":23803,"kind":"person","name":"Cook Meredith","position":1,"cik":"0001938861","reported_name":"Cook Meredith","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SR. VP, GENERAL COUNSEL & SEC."}}],"security":"Common Stock","published_at":"2026-09-15T00:56:53.000Z","date":"2026-09-14","kind":"sale","planned":true,"acquired":false,"shares":500,"price":70.79,"value":35395.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2025."}],"balance_after":73924,"source":{"system":"sec-edgar","filing":"0001938861-26-000026","document":"wk-form4_1789433811.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1938861/000193886126000026/wk-form4_1789433811.xml","form_type":"4"}},{"id":671530,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":18119,"kind":"person","name":"CAREY STEPHEN P.","position":1,"cik":"0001674236","reported_name":"CAREY STEPHEN P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & CFO"}}],"security":"Common Stock","published_at":"2026-09-01T22:18:41.000Z","date":"2026-08-31","kind":"sale","planned":true,"acquired":false,"shares":2850,"price":72.8,"value":207480.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 6, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares were sold in multiple trades at prices ranging from $71.89 to $73.36. The price reported above reflects the weighted average sales price."}],"balance_after":171843,"source":{"system":"sec-edgar","filing":"0001674236-26-000022","document":"wk-form4_1788301118.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000167423626000022/wk-form4_1788301118.xml","form_type":"4"}},{"id":674169,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":11607,"kind":"person","name":"Gosebruch Henry O","position":1,"cik":"0001659625","reported_name":"Gosebruch Henry O","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-08-27T20:21:57.000Z","date":"2026-08-19","kind":"grant","planned":false,"acquired":true,"shares":6662,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Represents a restricted stock award that will vest in three equal annual installments on the first, second and third anniversaries of August 19, 2026."}],"balance_after":6662,"source":{"system":"sec-edgar","filing":"0001659625-26-000011","document":"wk-form4_1787862115.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000165962526000011/wk-form4_1787862115.xml","form_type":"4"}},{"id":675429,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":19644,"kind":"person","name":"Lalwani Nikhil","position":1,"cik":"0001822629","reported_name":"Lalwani Nikhil","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT & CEO"}}],"security":"Common Stock","published_at":"2026-08-26T22:15:10.000Z","date":"2026-08-25","kind":"sale","planned":true,"acquired":false,"shares":5400,"price":74.3,"value":401220.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 26, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares were sold in multiple trades at prices ranging from $73.58 to $74.61. The price reported above reflects the weighted average sales price."}],"balance_after":344489,"source":{"system":"sec-edgar","filing":"0001822629-26-000014","document":"wk-form4_1787782508.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000182262926000014/wk-form4_1787782508.xml","form_type":"4"}},{"id":688313,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":23803,"kind":"person","name":"Cook Meredith","position":1,"cik":"0001938861","reported_name":"Cook Meredith","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SR. VP, GENERAL COUNSEL & SEC."}}],"security":"Common Stock","published_at":"2026-08-13T20:32:28.000Z","date":"2026-08-13","kind":"sale","planned":true,"acquired":false,"shares":500,"price":75.48,"value":37740.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2025."}],"balance_after":74424,"source":{"system":"sec-edgar","filing":"0001938861-26-000023","document":"wk-form4_1786653146.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000193886126000023/wk-form4_1786653146.xml","form_type":"4"}},{"id":691280,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":24759,"kind":"person","name":"Gutwerg Ori","position":1,"cik":"0001846478","reported_name":"Gutwerg Ori","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, GENERICS"}}],"security":"Common Stock","published_at":"2026-08-12T00:57:29.000Z","date":"2026-08-10","kind":"sale","planned":false,"acquired":false,"shares":3162,"price":77,"value":243474.0,"ownership":{"direct":true},"balance_after":75534,"source":{"system":"sec-edgar","filing":"0001846478-26-000015","document":"wk-form4_1786496247.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000184647826000015/wk-form4_1786496247.xml","form_type":"4"}},{"id":700917,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":18119,"kind":"person","name":"CAREY STEPHEN P.","position":1,"cik":"0001674236","reported_name":"CAREY STEPHEN P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & CFO"}}],"security":"Common Stock","published_at":"2026-07-30T20:02:55.000Z","date":"2026-07-29","kind":"sale","planned":true,"acquired":false,"shares":2850,"price":81.36,"value":231876.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 6, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares were sold in multiple trades at prices ranging from $80.61 to $81.88. The price reported above reflects the weighted average sales price."}],"balance_after":174693,"source":{"system":"sec-edgar","filing":"0001674236-26-000019","document":"wk-form4_1785441772.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000167423626000019/wk-form4_1785441772.xml","form_type":"4"}},{"id":705336,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":23803,"kind":"person","name":"Cook Meredith","position":1,"cik":"0001938861","reported_name":"Cook Meredith","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SR. VP, GENERAL COUNSEL & SEC."}}],"security":"Common Stock","published_at":"2026-07-21T20:32:05.000Z","date":"2026-07-18","kind":"tax_withholding","planned":false,"acquired":false,"shares":2466,"price":79.2,"value":195307.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 4,820 shares of restricted stock, the grant of which was previously reported on July 20, 2022."}],"balance_after":74924,"source":{"system":"sec-edgar","filing":"0001938861-26-000021","document":"wk-form4_1784665922.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000193886126000021/wk-form4_1784665922.xml","form_type":"4"}},{"id":710065,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":23803,"kind":"person","name":"Cook Meredith","position":1,"cik":"0001938861","reported_name":"Cook Meredith","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SR. VP, GENERAL COUNSEL & SEC."}}],"security":"Common Stock","published_at":"2026-07-14T20:02:06.000Z","date":"2026-07-13","kind":"sale","planned":true,"acquired":false,"shares":500,"price":81.84,"value":40920.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2025."}],"balance_after":77390,"source":{"system":"sec-edgar","filing":"0001938861-26-000019","document":"wk-form4_1784059323.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000193886126000019/wk-form4_1784059323.xml","form_type":"4"}},{"id":716156,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":18119,"kind":"person","name":"CAREY STEPHEN P.","position":1,"cik":"0001674236","reported_name":"CAREY STEPHEN P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & CFO"}}],"security":"Stock Option (right to buy)","published_at":"2026-07-07T01:40:18.000Z","date":"2026-07-02","kind":"exercise","planned":true,"acquired":false,"shares":3313,"price":49.51,"value":164026.63,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The stock option exercise and sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 6, 2026."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the total options vested on each of March 31, 2018, March 31, 2019, March 31, 2020, and March 31, 2021."}],"balance_after":3313,"derivative":{"exercise_price":49.51,"expiration_date":"2027-03-30","underlying":"Common Stock","underlying_shares":3313},"source":{"system":"sec-edgar","filing":"0001674236-26-000017","document":"wk-form4_1783388415.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000167423626000017/wk-form4_1783388415.xml","form_type":"4"}},{"id":716155,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":18119,"kind":"person","name":"CAREY STEPHEN P.","position":1,"cik":"0001674236","reported_name":"CAREY STEPHEN P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & CFO"}}],"security":"Common Stock","published_at":"2026-07-07T01:40:18.000Z","date":"2026-07-02","kind":"sale","planned":true,"acquired":false,"shares":3313,"price":86,"value":284918.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The stock option exercise and sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 6, 2026."}],"balance_after":177543,"source":{"system":"sec-edgar","filing":"0001674236-26-000017","document":"wk-form4_1783388415.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000167423626000017/wk-form4_1783388415.xml","form_type":"4"}},{"id":716154,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":18119,"kind":"person","name":"CAREY STEPHEN P.","position":1,"cik":"0001674236","reported_name":"CAREY STEPHEN P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & CFO"}}],"security":"Common Stock","published_at":"2026-07-07T01:40:18.000Z","date":"2026-07-02","kind":"exercise","planned":true,"acquired":true,"shares":3313,"price":49.51,"value":164026.63,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The stock option exercise and sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 6, 2026."}],"balance_after":180856,"source":{"system":"sec-edgar","filing":"0001674236-26-000017","document":"wk-form4_1783388415.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000167423626000017/wk-form4_1783388415.xml","form_type":"4"}},{"id":723185,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":18119,"kind":"person","name":"CAREY STEPHEN P.","position":1,"cik":"0001674236","reported_name":"CAREY STEPHEN P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & CFO"}}],"security":"Common Stock","published_at":"2026-06-30T20:14:39.000Z","date":"2026-06-29","kind":"sale","planned":true,"acquired":false,"shares":2850,"price":84.12,"value":239742.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 6, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares were sold in multiple trades at prices ranging from $83.39 to $84.63. The price reported above reflects the weighted average sales price."}],"balance_after":177543,"source":{"system":"sec-edgar","filing":"0001674236-26-000015","document":"wk-form4_1782850477.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000167423626000015/wk-form4_1782850477.xml","form_type":"4"}},{"id":738394,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":23803,"kind":"person","name":"Cook Meredith","position":1,"cik":"0001938861","reported_name":"Cook Meredith","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SR. VP, GENERAL COUNSEL & SEC."}}],"security":"Common Stock","published_at":"2026-06-15T22:44:30.000Z","date":"2026-06-12","kind":"sale","planned":true,"acquired":false,"shares":500,"price":82.03,"value":41015.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2025."}],"balance_after":77890,"source":{"system":"sec-edgar","filing":"0001938861-26-000017","document":"wk-form4_1781563468.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000193886126000017/wk-form4_1781563468.xml","form_type":"4"}},{"id":743712,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":39807,"kind":"person","name":"Thoma Jeanne","position":1,"cik":"0001819879","reported_name":"Thoma Jeanne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-11T01:10:23.000Z","date":"2026-05-21","kind":"grant","planned":false,"acquired":true,"shares":4357,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a restricted stock award that will vest in full on May 21, 2027."}],"balance_after":27762,"source":{"system":"sec-edgar","filing":"0001819879-26-000003","document":"wk-form4_1781140220.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000181987926000003/wk-form4_1781140220.xml","form_type":"4"}},{"id":743711,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":38091,"kind":"person","name":"TANNENBAUM RENEE P","position":1,"cik":"0001543174","reported_name":"TANNENBAUM RENEE P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-11T01:09:17.000Z","date":"2026-05-21","kind":"grant","planned":false,"acquired":true,"shares":4357,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a restricted stock award that will vest in full on May 21, 2027."}],"balance_after":29514,"source":{"system":"sec-edgar","filing":"0001543174-26-000003","document":"wk-form4_1781140154.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000154317426000003/wk-form4_1781140154.xml","form_type":"4"}},{"id":743710,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":39806,"kind":"person","name":"Pera Antonio R","position":1,"cik":"0001689325","reported_name":"Pera Antonio R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-11T01:08:22.000Z","date":"2026-05-21","kind":"grant","planned":false,"acquired":true,"shares":4357,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a restricted stock award that will vest in full on May 21, 2027."}],"balance_after":27017,"source":{"system":"sec-edgar","filing":"0001689325-26-000003","document":"wk-form4_1781140099.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000168932526000003/wk-form4_1781140099.xml","form_type":"4"}},{"id":743709,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":39805,"kind":"person","name":"Leonard Matthew J","position":1,"cik":"0001773152","reported_name":"Leonard Matthew J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-11T01:08:03.000Z","date":"2026-05-21","kind":"grant","planned":false,"acquired":true,"shares":4357,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a restricted stock award that will vest in full on May 21, 2027."}],"balance_after":11221,"source":{"system":"sec-edgar","filing":"0001773152-26-000003","document":"wk-form4_1781140081.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000177315226000003/wk-form4_1781140081.xml","form_type":"4"}},{"id":743706,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":39804,"kind":"person","name":"HAUGHEY THOMAS","position":1,"cik":"0001272247","reported_name":"HAUGHEY THOMAS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-11T01:06:55.000Z","date":"2026-06-08","kind":"sale","planned":true,"acquired":false,"shares":2000,"price":80.88,"value":161760.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 9, 2026."}],"balance_after":38878,"source":{"system":"sec-edgar","filing":"0001272247-26-000004","document":"wk-form4_1781140013.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000127224726000004/wk-form4_1781140013.xml","form_type":"4"}},{"id":743705,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":39804,"kind":"person","name":"HAUGHEY THOMAS","position":1,"cik":"0001272247","reported_name":"HAUGHEY THOMAS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-11T01:06:55.000Z","date":"2026-05-21","kind":"grant","planned":true,"acquired":true,"shares":4357,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a restricted stock award that will vest in full on May 21, 2027."}],"balance_after":40878,"source":{"system":"sec-edgar","filing":"0001272247-26-000004","document":"wk-form4_1781140013.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000127224726000004/wk-form4_1781140013.xml","form_type":"4"}},{"id":745245,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":18119,"kind":"person","name":"CAREY STEPHEN P.","position":1,"cik":"0001674236","reported_name":"CAREY STEPHEN P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & CFO"}}],"security":"Stock Option (right to buy)","published_at":"2026-06-09T22:33:44.000Z","date":"2026-06-05","kind":"exercise","planned":true,"acquired":false,"shares":3312,"price":49.51,"value":163977.12,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The stock option exercise and sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 6, 2026."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the total options vested on each of March 31, 2018, March 31, 2019, March 31, 2020, and March 31, 2021."}],"balance_after":6626,"derivative":{"exercise_price":49.51,"expiration_date":"2027-03-30","underlying":"Common Stock","underlying_shares":3312},"source":{"system":"sec-edgar","filing":"0001674236-26-000013","document":"wk-form4_1781044421.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000167423626000013/wk-form4_1781044421.xml","form_type":"4"}},{"id":745244,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":18119,"kind":"person","name":"CAREY STEPHEN P.","position":1,"cik":"0001674236","reported_name":"CAREY STEPHEN P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & CFO"}}],"security":"Common Stock","published_at":"2026-06-09T22:33:44.000Z","date":"2026-06-05","kind":"sale","planned":true,"acquired":false,"shares":3312,"price":80,"value":264960.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The stock option exercise and sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 6, 2026."}],"balance_after":180393,"source":{"system":"sec-edgar","filing":"0001674236-26-000013","document":"wk-form4_1781044421.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000167423626000013/wk-form4_1781044421.xml","form_type":"4"}},{"id":745243,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":18119,"kind":"person","name":"CAREY STEPHEN P.","position":1,"cik":"0001674236","reported_name":"CAREY STEPHEN P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & CFO"}}],"security":"Common Stock","published_at":"2026-06-09T22:33:44.000Z","date":"2026-06-05","kind":"exercise","planned":true,"acquired":true,"shares":3312,"price":49.51,"value":163977.12,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The stock option exercise and sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 6, 2026."}],"balance_after":183705,"source":{"system":"sec-edgar","filing":"0001674236-26-000013","document":"wk-form4_1781044421.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000167423626000013/wk-form4_1781044421.xml","form_type":"4"}},{"id":781379,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":47770,"kind":"person","name":"Walsh Patrick D","position":1,"cik":"0001720568","reported_name":"Walsh Patrick D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-14T00:22:10.000Z","date":"2026-05-13","kind":"sale","planned":false,"acquired":false,"shares":10000,"price":80.63,"value":806300.0,"ownership":{"direct":true},"balance_after":38432,"source":{"system":"sec-edgar","filing":"0001720568-26-000005","document":"wk-form4_1778718127.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000172056826000005/wk-form4_1778718127.xml","form_type":"4"}},{"id":781378,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":47770,"kind":"person","name":"Walsh Patrick D","position":1,"cik":"0001720568","reported_name":"Walsh Patrick D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-14T00:22:10.000Z","date":"2026-05-11","kind":"sale","planned":false,"acquired":false,"shares":3973,"price":80.75,"value":320819.75,"ownership":{"direct":true},"balance_after":48432,"source":{"system":"sec-edgar","filing":"0001720568-26-000005","document":"wk-form4_1778718127.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000172056826000005/wk-form4_1778718127.xml","form_type":"4"}},{"id":781377,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":47769,"kind":"person","name":"Rowland Thomas Andrew","position":1,"cik":"0001507496","reported_name":"Rowland Thomas Andrew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, HEAD - ESTABLISHED BRANDS"}}],"security":"Common Stock","published_at":"2026-05-13T20:16:49.000Z","date":"2026-05-12","kind":"sale","planned":false,"acquired":false,"shares":459,"price":79.21,"value":36357.39,"ownership":{"direct":true},"balance_after":38271,"source":{"system":"sec-edgar","filing":"0001507496-26-000012","document":"wk-form4_1778703407.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000150749626000012/wk-form4_1778703407.xml","form_type":"4"}},{"id":781376,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":19644,"kind":"person","name":"Lalwani Nikhil","position":1,"cik":"0001822629","reported_name":"Lalwani Nikhil","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT & CEO"}}],"security":"Common Stock","published_at":"2026-05-13T20:16:23.000Z","date":"2026-05-11","kind":"sale","planned":false,"acquired":false,"shares":55000,"price":77.57,"value":4266350.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were sold in multiple trades at prices ranging from $76.21 to $80.38. The price reported above reflects the weighted average sales price."}],"balance_after":349889,"source":{"system":"sec-edgar","filing":"0001822629-26-000011","document":"wk-form4_1778703381.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000182262926000011/wk-form4_1778703381.xml","form_type":"4"}},{"id":781375,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":24759,"kind":"person","name":"Gutwerg Ori","position":1,"cik":"0001846478","reported_name":"Gutwerg Ori","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, GENERICS"}}],"security":"Common Stock","published_at":"2026-05-13T20:15:49.000Z","date":"2026-05-12","kind":"sale","planned":false,"acquired":false,"shares":2772,"price":79.5,"value":220374.0,"ownership":{"direct":true},"balance_after":78696,"source":{"system":"sec-edgar","filing":"0001846478-26-000013","document":"wk-form4_1778703345.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000184647826000013/wk-form4_1778703345.xml","form_type":"4"}},{"id":781373,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":23803,"kind":"person","name":"Cook Meredith","position":1,"cik":"0001938861","reported_name":"Cook Meredith","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SR. VP, GENERAL COUNSEL & SEC."}}],"security":"Common Stock","published_at":"2026-05-13T20:15:29.000Z","date":"2026-05-13","kind":"sale","planned":true,"acquired":false,"shares":500,"price":78.16,"value":39080.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2025."}],"balance_after":78390,"source":{"system":"sec-edgar","filing":"0001938861-26-000015","document":"wk-form4_1778703326.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000193886126000015/wk-form4_1778703326.xml","form_type":"4"}},{"id":809927,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":23803,"kind":"person","name":"Cook Meredith","position":1,"cik":"0001938861","reported_name":"Cook Meredith","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SR. VP, GENERAL COUNSEL & SEC."}}],"security":"Common Stock","published_at":"2026-04-13T20:40:36.000Z","date":"2026-04-13","kind":"sale","planned":true,"acquired":false,"shares":500,"price":77.95,"value":38975.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2025."}],"balance_after":78890,"source":{"system":"sec-edgar","filing":"0001938861-26-000013","document":"wk-form4_1776112832.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000193886126000013/wk-form4_1776112832.xml","form_type":"4"}},{"id":844627,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":47769,"kind":"person","name":"Rowland Thomas Andrew","position":1,"cik":"0001507496","reported_name":"Rowland Thomas Andrew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, HEAD - ESTABLISHED BRANDS"}}],"security":"Common Stock","published_at":"2026-03-13T21:28:48.000Z","date":"2026-03-11","kind":"sale","planned":false,"acquired":false,"shares":4772,"price":74.91,"value":357470.52,"ownership":{"direct":true},"balance_after":38730,"source":{"system":"sec-edgar","filing":"0001507496-26-000009","document":"wk-form4_1773437312.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000150749626000009/wk-form4_1773437312.xml","form_type":"4"}},{"id":844624,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":61088,"kind":"person","name":"Mutz Christopher","position":1,"cik":"0001846487","reported_name":"Mutz Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"HEAD OF RARE DISEASE"}}],"security":"Common Stock","published_at":"2026-03-13T21:28:46.000Z","date":"2026-03-13","kind":"sale","planned":true,"acquired":false,"shares":3162,"price":71.64,"value":226525.68,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 16, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares were sold in multiple trades at prices ranging from $70.27 to $72.62. The price reported above reflects the weighted average sales price."}],"balance_after":91309,"source":{"system":"sec-edgar","filing":"0001846487-26-000014","document":"wk-form4_1773437295.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000184648726000014/wk-form4_1773437295.xml","form_type":"4"}},{"id":844623,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":23803,"kind":"person","name":"Cook Meredith","position":1,"cik":"0001938861","reported_name":"Cook Meredith","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SR. VP, GENERAL COUNSEL & SEC."}}],"security":"Common Stock","published_at":"2026-03-13T21:28:45.000Z","date":"2026-03-13","kind":"sale","planned":true,"acquired":false,"shares":500,"price":72.62,"value":36310.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2025."}],"balance_after":79390,"source":{"system":"sec-edgar","filing":"0001938861-26-000010","document":"wk-form4_1773437283.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000193886126000010/wk-form4_1773437283.xml","form_type":"4"}},{"id":851882,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":61088,"kind":"person","name":"Mutz Christopher","position":1,"cik":"0001846487","reported_name":"Mutz Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"HEAD OF RARE DISEASE"}}],"security":"Common Stock","published_at":"2026-03-10T20:09:44.000Z","date":"2026-03-09","kind":"sale","planned":true,"acquired":false,"shares":3602,"price":74.18,"value":267196.36,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 16, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The shares were sold in multiple trades at prices ranging from $73.27 to $74.81. The price reported above reflects the weighted average sales price."}],"balance_after":94471,"source":{"system":"sec-edgar","filing":"0001846487-26-000012","document":"wk-form4_1773173381.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000184648726000012/wk-form4_1773173381.xml","form_type":"4"}},{"id":851881,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":61088,"kind":"person","name":"Mutz Christopher","position":1,"cik":"0001846487","reported_name":"Mutz Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"HEAD OF RARE DISEASE"}}],"security":"Common Stock","published_at":"2026-03-10T20:09:44.000Z","date":"2026-03-07","kind":"tax_withholding","planned":true,"acquired":false,"shares":3314,"price":74.04,"value":245368.56,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 6,476 shares of restricted stock, the grant of which was previously reported."}],"balance_after":98073,"source":{"system":"sec-edgar","filing":"0001846487-26-000012","document":"wk-form4_1773173381.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000184648726000012/wk-form4_1773173381.xml","form_type":"4"}},{"id":851880,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":61088,"kind":"person","name":"Mutz Christopher","position":1,"cik":"0001846487","reported_name":"Mutz Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"HEAD OF RARE DISEASE"}}],"security":"Common Stock","published_at":"2026-03-10T20:09:44.000Z","date":"2026-03-06","kind":"sale","planned":true,"acquired":false,"shares":2121,"price":74.22,"value":157420.62,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 16, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares were sold in multiple trades at prices ranging from $73.14 to $75.00. The price reported above reflects the weighted average sales price."}],"balance_after":101387,"source":{"system":"sec-edgar","filing":"0001846487-26-000012","document":"wk-form4_1773173381.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000184648726000012/wk-form4_1773173381.xml","form_type":"4"}},{"id":851879,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":19644,"kind":"person","name":"Lalwani Nikhil","position":1,"cik":"0001822629","reported_name":"Lalwani Nikhil","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT & CEO"}}],"security":"Common Stock","published_at":"2026-03-10T20:09:20.000Z","date":"2026-03-07","kind":"tax_withholding","planned":false,"acquired":false,"shares":17060,"price":74.04,"value":1263122.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 33,352 shares of restricted stock, the grant of which was previously reported."}],"balance_after":404889,"source":{"system":"sec-edgar","filing":"0001822629-26-000008","document":"wk-form4_1773173356.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000182262926000008/wk-form4_1773173356.xml","form_type":"4"}},{"id":851878,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":24759,"kind":"person","name":"Gutwerg Ori","position":1,"cik":"0001846478","reported_name":"Gutwerg Ori","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, GENERICS"}}],"security":"Common Stock","published_at":"2026-03-10T20:07:12.000Z","date":"2026-03-07","kind":"tax_withholding","planned":false,"acquired":false,"shares":3314,"price":74.04,"value":245368.56,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 6,476 shares of restricted stock, the grant of which was previously reported."}],"balance_after":81468,"source":{"system":"sec-edgar","filing":"0001846478-26-000010","document":"wk-form4_1773173229.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000184647826000010/wk-form4_1773173229.xml","form_type":"4"}},{"id":851876,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":61838,"kind":"person","name":"Davis Krista","position":1,"cik":"0001946439","reported_name":"Davis Krista","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CHIEF HR OFFICER"}}],"security":"Common Stock","published_at":"2026-03-10T20:06:32.000Z","date":"2026-03-09","kind":"sale","planned":true,"acquired":false,"shares":5087,"price":74.13,"value":377099.31,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 18, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares were sold in multiple trades at prices ranging from $72.94 to $74.76. The price reported above reflects the weighted average sales price."}],"balance_after":51946,"source":{"system":"sec-edgar","filing":"0001946439-26-000010","document":"wk-form4_1773173188.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000194643926000010/wk-form4_1773173188.xml","form_type":"4"}},{"id":851875,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":61838,"kind":"person","name":"Davis Krista","position":1,"cik":"0001946439","reported_name":"Davis Krista","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CHIEF HR OFFICER"}}],"security":"Common Stock","published_at":"2026-03-10T20:06:32.000Z","date":"2026-03-06","kind":"sale","planned":true,"acquired":false,"shares":1485,"price":75,"value":111375.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 18, 2025."}],"balance_after":57033,"source":{"system":"sec-edgar","filing":"0001946439-26-000010","document":"wk-form4_1773173188.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000194643926000010/wk-form4_1773173188.xml","form_type":"4"}},{"id":851877,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":18119,"kind":"person","name":"CAREY STEPHEN P.","position":1,"cik":"0001674236","reported_name":"CAREY STEPHEN P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & CFO"}}],"security":"Common Stock","published_at":"2026-03-10T20:04:42.000Z","date":"2026-03-07","kind":"tax_withholding","planned":false,"acquired":false,"shares":5150,"price":74.04,"value":381306.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 11,292 shares of restricted stock, the grant of which was previously reported."}],"balance_after":180393,"source":{"system":"sec-edgar","filing":"0001674236-26-000010","document":"wk-form4_1773173079.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000167423626000010/wk-form4_1773173079.xml","form_type":"4"}},{"id":859484,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":18119,"kind":"person","name":"CAREY STEPHEN P.","position":1,"cik":"0001674236","reported_name":"CAREY STEPHEN P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & CFO"}}],"security":"Stock Option (right to buy)","published_at":"2026-03-05T22:46:28.000Z","date":"2026-03-05","kind":"exercise","planned":false,"acquired":false,"shares":3312,"price":49.51,"value":163977.12,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the total options vested on each of March 31, 2018, March 31, 2019, March 31, 2020, and March 31, 2021."}],"balance_after":9938,"derivative":{"exercise_price":49.51,"expiration_date":"2027-03-30","underlying":"Common Stock","underlying_shares":3312},"source":{"system":"sec-edgar","filing":"0001674236-26-000008","document":"wk-form4_1772750785.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000167423626000008/wk-form4_1772750785.xml","form_type":"4"}},{"id":859483,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":18119,"kind":"person","name":"CAREY STEPHEN P.","position":1,"cik":"0001674236","reported_name":"CAREY STEPHEN P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & CFO"}}],"security":"Common Stock","published_at":"2026-03-05T22:46:28.000Z","date":"2026-03-05","kind":"sale","planned":false,"acquired":false,"shares":4000,"price":75.56,"value":302240.0,"ownership":{"direct":true},"balance_after":185543,"source":{"system":"sec-edgar","filing":"0001674236-26-000008","document":"wk-form4_1772750785.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000167423626000008/wk-form4_1772750785.xml","form_type":"4"}},{"id":859482,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":18119,"kind":"person","name":"CAREY STEPHEN P.","position":1,"cik":"0001674236","reported_name":"CAREY STEPHEN P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & CFO"}}],"security":"Common Stock","published_at":"2026-03-05T22:46:28.000Z","date":"2026-03-05","kind":"sale","planned":false,"acquired":false,"shares":3312,"price":75.42,"value":249791.04,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were sold in multiple trades at prices ranging from $75.41 to $75.56. The price reported above reflects the weighted average sales price."}],"balance_after":189543,"source":{"system":"sec-edgar","filing":"0001674236-26-000008","document":"wk-form4_1772750785.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000167423626000008/wk-form4_1772750785.xml","form_type":"4"}},{"id":859481,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":18119,"kind":"person","name":"CAREY STEPHEN P.","position":1,"cik":"0001674236","reported_name":"CAREY STEPHEN P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & CFO"}}],"security":"Common Stock","published_at":"2026-03-05T22:46:28.000Z","date":"2026-03-05","kind":"exercise","planned":false,"acquired":true,"shares":3312,"price":49.51,"value":163977.12,"ownership":{"direct":true},"balance_after":192855,"source":{"system":"sec-edgar","filing":"0001674236-26-000008","document":"wk-form4_1772750785.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000167423626000008/wk-form4_1772750785.xml","form_type":"4"}},{"id":863067,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":61088,"kind":"person","name":"Mutz Christopher","position":1,"cik":"0001846487","reported_name":"Mutz Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"HEAD OF RARE DISEASE"}}],"security":"Common Stock","published_at":"2026-03-04T23:46:47.000Z","date":"2026-03-02","kind":"sale","planned":true,"acquired":false,"shares":417,"price":74,"value":30858.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 16, 2025."}],"balance_after":103508,"source":{"system":"sec-edgar","filing":"0001846487-26-000010","document":"wk-form4_1772668004.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000184648726000010/wk-form4_1772668004.xml","form_type":"4"}},{"id":863066,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":24759,"kind":"person","name":"Gutwerg Ori","position":1,"cik":"0001846478","reported_name":"Gutwerg Ori","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, GENERICS"}}],"security":"Common Stock","published_at":"2026-03-04T23:45:48.000Z","date":"2026-03-03","kind":"sale","planned":false,"acquired":false,"shares":2060,"price":76.5,"value":157590.0,"ownership":{"direct":true},"balance_after":84782,"source":{"system":"sec-edgar","filing":"0001846478-26-000008","document":"wk-form4_1772667946.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000184647826000008/wk-form4_1772667946.xml","form_type":"4"}},{"id":870195,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":47770,"kind":"person","name":"Walsh Patrick D","position":1,"cik":"0001720568","reported_name":"Walsh Patrick D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-03-03T23:01:04.000Z","date":"2026-03-03","kind":"sale","planned":false,"acquired":false,"shares":6000,"price":74.23,"value":445380.0,"ownership":{"direct":true},"balance_after":52405,"source":{"system":"sec-edgar","filing":"0001720568-26-000002","document":"wk-form4_1772578861.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000172056826000002/wk-form4_1772578861.xml","form_type":"4"}},{"id":875181,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":64060,"kind":"person","name":"Shanmugam Muthusamy","position":1,"cik":"0001870913","reported_name":"Shanmugam Muthusamy","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"HEAD OF R&D, COO-NOVITIUM OPS"}}],"security":"Common Stock","published_at":"2026-03-02T22:59:46.000Z","date":"2026-02-26","kind":"grant","planned":false,"acquired":true,"shares":11116,"price":77.15,"value":857599.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a restricted stock award that will vest in four equal annual installments on the first, second, third and fourth anniversaries of February 26, 2026."}],"balance_after":101056,"source":{"system":"sec-edgar","filing":"0001870913-26-000005","document":"wk-form4_1772492383.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000187091326000005/wk-form4_1772492383.xml","form_type":"4"}},{"id":875180,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":47769,"kind":"person","name":"Rowland Thomas Andrew","position":1,"cik":"0001507496","reported_name":"Rowland Thomas Andrew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, HEAD - ESTABLISHED BRANDS"}}],"security":"Common Stock","published_at":"2026-03-02T22:59:32.000Z","date":"2026-02-28","kind":"tax_withholding","planned":false,"acquired":false,"shares":628,"price":73.9,"value":46409.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 2,171 shares of restricted stock, the grant of which was previously reported."}],"balance_after":43502,"source":{"system":"sec-edgar","filing":"0001507496-26-000007","document":"wk-form4_1772492369.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000150749626000007/wk-form4_1772492369.xml","form_type":"4"}},{"id":875179,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":47769,"kind":"person","name":"Rowland Thomas Andrew","position":1,"cik":"0001507496","reported_name":"Rowland Thomas Andrew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, HEAD - ESTABLISHED BRANDS"}}],"security":"Common Stock","published_at":"2026-03-02T22:59:32.000Z","date":"2026-02-26","kind":"grant","planned":false,"acquired":true,"shares":6021,"price":77.15,"value":464520.15,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a restricted stock award that will vest in four equal annual installments on the first, second, third and fourth anniversaries of February 26, 2026."}],"balance_after":44130,"source":{"system":"sec-edgar","filing":"0001507496-26-000007","document":"wk-form4_1772492369.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000150749626000007/wk-form4_1772492369.xml","form_type":"4"}},{"id":875178,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":61088,"kind":"person","name":"Mutz Christopher","position":1,"cik":"0001846487","reported_name":"Mutz Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"HEAD OF RARE DISEASE"}}],"security":"Common Stock","published_at":"2026-03-02T22:59:15.000Z","date":"2026-02-28","kind":"tax_withholding","planned":false,"acquired":false,"shares":2221,"price":73.9,"value":164131.9,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 4,342 shares of restricted stock, the grant of which was previously reported."}],"balance_after":103925,"source":{"system":"sec-edgar","filing":"0001846487-26-000008","document":"wk-form4_1772492353.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000184648726000008/wk-form4_1772492353.xml","form_type":"4"}},{"id":875177,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":61088,"kind":"person","name":"Mutz Christopher","position":1,"cik":"0001846487","reported_name":"Mutz Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"HEAD OF RARE DISEASE"}}],"security":"Common Stock","published_at":"2026-03-02T22:59:15.000Z","date":"2026-02-26","kind":"grant","planned":false,"acquired":true,"shares":21306,"price":77.15,"value":1643757.9,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a restricted stock award that will vest in four equal annual installments on the first, second, third and fourth anniversaries of February 26, 2026."}],"balance_after":106146,"source":{"system":"sec-edgar","filing":"0001846487-26-000008","document":"wk-form4_1772492353.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000184648726000008/wk-form4_1772492353.xml","form_type":"4"}},{"id":875174,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":19644,"kind":"person","name":"Lalwani Nikhil","position":1,"cik":"0001822629","reported_name":"Lalwani Nikhil","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT & CEO"}}],"security":"Common Stock","published_at":"2026-03-02T22:58:54.000Z","date":"2026-02-28","kind":"tax_withholding","planned":false,"acquired":false,"shares":12217,"price":73.9,"value":902836.3,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 23,883 shares of restricted stock, the grant of which was previously reported."}],"balance_after":421949,"source":{"system":"sec-edgar","filing":"0001822629-26-000006","document":"wk-form4_1772492331.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000182262926000006/wk-form4_1772492331.xml","form_type":"4"}},{"id":875173,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":19644,"kind":"person","name":"Lalwani Nikhil","position":1,"cik":"0001822629","reported_name":"Lalwani Nikhil","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT & CEO"}}],"security":"Common Stock","published_at":"2026-03-02T22:58:54.000Z","date":"2026-02-26","kind":"grant","planned":false,"acquired":true,"shares":75592,"price":77.15,"value":5831922.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a restricted stock award that will vest in four equal annual installments on the first, second, third and fourth anniversaries of February 26, 2026."}],"balance_after":434166,"source":{"system":"sec-edgar","filing":"0001822629-26-000006","document":"wk-form4_1772492331.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000182262926000006/wk-form4_1772492331.xml","form_type":"4"}},{"id":875176,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":24759,"kind":"person","name":"Gutwerg Ori","position":1,"cik":"0001846478","reported_name":"Gutwerg Ori","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, GENERICS"}}],"security":"Common Stock","published_at":"2026-03-02T22:58:40.000Z","date":"2026-02-28","kind":"tax_withholding","planned":false,"acquired":false,"shares":2221,"price":73.9,"value":164131.9,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 4,342 shares of restricted stock, the grant of which was previously reported."}],"balance_after":86842,"source":{"system":"sec-edgar","filing":"0001846478-26-000006","document":"wk-form4_1772492317.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000184647826000006/wk-form4_1772492317.xml","form_type":"4"}},{"id":875175,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":24759,"kind":"person","name":"Gutwerg Ori","position":1,"cik":"0001846478","reported_name":"Gutwerg Ori","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, GENERICS"}}],"security":"Common Stock","published_at":"2026-03-02T22:58:40.000Z","date":"2026-02-26","kind":"grant","planned":false,"acquired":true,"shares":12969,"price":77.15,"value":1000558.35,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a restricted stock award that will vest in four equal annual installments on the first, second, third and fourth anniversaries of February 26, 2026."}],"balance_after":89063,"source":{"system":"sec-edgar","filing":"0001846478-26-000006","document":"wk-form4_1772492317.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000184647826000006/wk-form4_1772492317.xml","form_type":"4"}},{"id":875172,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":64059,"kind":"person","name":"Gassert Chad","position":1,"cik":"0001871002","reported_name":"Gassert Chad","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP - CORP. DEV. & STRATEGY"}}],"security":"Common Stock","published_at":"2026-03-02T22:58:22.000Z","date":"2026-02-28","kind":"tax_withholding","planned":false,"acquired":false,"shares":2221,"price":73.9,"value":164131.9,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 4,342 shares of restricted stock, the grant of which was previously reported."}],"balance_after":74916,"source":{"system":"sec-edgar","filing":"0001871002-26-000006","document":"wk-form4_1772492300.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000187100226000006/wk-form4_1772492300.xml","form_type":"4"}},{"id":875171,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":64059,"kind":"person","name":"Gassert Chad","position":1,"cik":"0001871002","reported_name":"Gassert Chad","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP - CORP. DEV. & STRATEGY"}}],"security":"Common Stock","published_at":"2026-03-02T22:58:22.000Z","date":"2026-02-26","kind":"grant","planned":false,"acquired":true,"shares":11116,"price":77.15,"value":857599.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a restricted stock award that will vest in four equal annual installments on the first, second, third and fourth anniversaries of February 26, 2026."}],"balance_after":77137,"source":{"system":"sec-edgar","filing":"0001871002-26-000006","document":"wk-form4_1772492300.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000187100226000006/wk-form4_1772492300.xml","form_type":"4"}},{"id":875170,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":61838,"kind":"person","name":"Davis Krista","position":1,"cik":"0001946439","reported_name":"Davis Krista","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CHIEF HR OFFICER"}}],"security":"Common Stock","published_at":"2026-03-02T22:57:59.000Z","date":"2026-02-28","kind":"tax_withholding","planned":false,"acquired":false,"shares":1555,"price":73.9,"value":114914.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 3,040 shares of restricted stock, the grant of which was previously reported."}],"balance_after":58518,"source":{"system":"sec-edgar","filing":"0001946439-26-000008","document":"wk-form4_1772492277.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000194643926000008/wk-form4_1772492277.xml","form_type":"4"}},{"id":875169,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":61838,"kind":"person","name":"Davis Krista","position":1,"cik":"0001946439","reported_name":"Davis Krista","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CHIEF HR OFFICER"}}],"security":"Common Stock","published_at":"2026-03-02T22:57:59.000Z","date":"2026-02-26","kind":"grant","planned":false,"acquired":true,"shares":10810,"price":77.15,"value":833991.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a restricted stock award that will vest in four equal annual installments on the first, second, third and fourth anniversaries of February 26, 2026."}],"balance_after":60073,"source":{"system":"sec-edgar","filing":"0001946439-26-000008","document":"wk-form4_1772492277.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000194643926000008/wk-form4_1772492277.xml","form_type":"4"}},{"id":875168,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":23803,"kind":"person","name":"Cook Meredith","position":1,"cik":"0001938861","reported_name":"Cook Meredith","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SR. VP, GENERAL COUNSEL & SEC."}}],"security":"Common Stock","published_at":"2026-03-02T22:57:44.000Z","date":"2026-02-28","kind":"tax_withholding","planned":false,"acquired":false,"shares":1555,"price":73.9,"value":114914.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 3,040 shares of restricted stock, the grant of which was previously reported."}],"balance_after":79890,"source":{"system":"sec-edgar","filing":"0001938861-26-000008","document":"wk-form4_1772492262.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000193886126000008/wk-form4_1772492262.xml","form_type":"4"}},{"id":875167,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":23803,"kind":"person","name":"Cook Meredith","position":1,"cik":"0001938861","reported_name":"Cook Meredith","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SR. VP, GENERAL COUNSEL & SEC."}}],"security":"Common Stock","published_at":"2026-03-02T22:57:44.000Z","date":"2026-02-26","kind":"grant","planned":false,"acquired":true,"shares":13895,"price":77.15,"value":1071999.25,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a restricted stock award that will vest in four equal annual installments on the first, second, third and fourth anniversaries of February 26, 2026."}],"balance_after":81445,"source":{"system":"sec-edgar","filing":"0001938861-26-000008","document":"wk-form4_1772492262.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000193886126000008/wk-form4_1772492262.xml","form_type":"4"}},{"id":875166,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":18119,"kind":"person","name":"CAREY STEPHEN P.","position":1,"cik":"0001674236","reported_name":"CAREY STEPHEN P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & CFO"}}],"security":"Common Stock","published_at":"2026-03-02T22:57:30.000Z","date":"2026-02-28","kind":"tax_withholding","planned":false,"acquired":false,"shares":2773,"price":73.9,"value":204924.7,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 6,079 shares of restricted stock, the grant of which was previously reported."}],"balance_after":189543,"source":{"system":"sec-edgar","filing":"0001674236-26-000006","document":"wk-form4_1772492247.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000167423626000006/wk-form4_1772492247.xml","form_type":"4"}},{"id":875165,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":18119,"kind":"person","name":"CAREY STEPHEN P.","position":1,"cik":"0001674236","reported_name":"CAREY STEPHEN P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & CFO"}}],"security":"Common Stock","published_at":"2026-03-02T22:57:30.000Z","date":"2026-02-26","kind":"grant","planned":false,"acquired":true,"shares":22233,"price":77.15,"value":1715275.95,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a restricted stock award that will vest in four equal annual installments on the first, second, third and fourth anniversaries of February 26, 2026."}],"balance_after":192316,"source":{"system":"sec-edgar","filing":"0001674236-26-000006","document":"wk-form4_1772492247.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000167423626000006/wk-form4_1772492247.xml","form_type":"4"}},{"id":888917,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":61088,"kind":"person","name":"Mutz Christopher","position":1,"cik":"0001846487","reported_name":"Mutz Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"HEAD OF RARE DISEASE"}}],"security":"Common Stock","published_at":"2026-02-23T22:31:50.000Z","date":"2026-02-20","kind":"sale","planned":true,"acquired":false,"shares":5323,"price":78.02,"value":415300.46,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 16, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares were sold in multiple trades at prices ranging from $77.20 to $78.58. The price reported above reflects the weighted average sales price."}],"balance_after":84840,"source":{"system":"sec-edgar","filing":"0001846487-26-000006","document":"wk-form4_1771885908.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000184648726000006/wk-form4_1771885908.xml","form_type":"4"}},{"id":888916,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":61838,"kind":"person","name":"Davis Krista","position":1,"cik":"0001946439","reported_name":"Davis Krista","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CHIEF HR OFFICER"}}],"security":"Common Stock","published_at":"2026-02-23T22:31:33.000Z","date":"2026-02-20","kind":"sale","planned":true,"acquired":false,"shares":1730,"price":77.99,"value":134922.7,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 18, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares were sold in multiple trades at prices ranging from $77.45 to $78.58. The price reported above reflects the weighted average sales price."}],"balance_after":49263,"source":{"system":"sec-edgar","filing":"0001946439-26-000006","document":"wk-form4_1771885891.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000194643926000006/wk-form4_1771885891.xml","form_type":"4"}},{"id":888915,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":61838,"kind":"person","name":"Davis Krista","position":1,"cik":"0001946439","reported_name":"Davis Krista","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CHIEF HR OFFICER"}}],"security":"Common Stock","published_at":"2026-02-23T22:31:33.000Z","date":"2026-02-19","kind":"sale","planned":true,"acquired":false,"shares":2084,"price":77.53,"value":161572.52,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 18, 2025."}],"balance_after":50993,"source":{"system":"sec-edgar","filing":"0001946439-26-000006","document":"wk-form4_1771885891.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000194643926000006/wk-form4_1771885891.xml","form_type":"4"}},{"id":902021,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":47769,"kind":"person","name":"Rowland Thomas Andrew","position":1,"cik":"0001507496","reported_name":"Rowland Thomas Andrew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, HEAD - ESTABLISHED BRANDS"}}],"security":"Common Stock","published_at":"2026-02-17T21:08:52.000Z","date":"2026-02-14","kind":"tax_withholding","planned":false,"acquired":false,"shares":485,"price":77.36,"value":37519.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 1,677 shares of restricted stock, the grant of which was previously reported."}],"balance_after":38109,"source":{"system":"sec-edgar","filing":"0001507496-26-000005","document":"wk-form4_1771362529.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000150749626000005/wk-form4_1771362529.xml","form_type":"4"}},{"id":902020,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":47769,"kind":"person","name":"Rowland Thomas Andrew","position":1,"cik":"0001507496","reported_name":"Rowland Thomas Andrew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, HEAD - ESTABLISHED BRANDS"}}],"security":"Common Stock","published_at":"2026-02-17T21:08:52.000Z","date":"2026-02-12","kind":"tax_withholding","planned":false,"acquired":false,"shares":566,"price":76.7,"value":43412.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 1,958 shares of restricted stock, the grant of which was previously reported."}],"balance_after":38594,"source":{"system":"sec-edgar","filing":"0001507496-26-000005","document":"wk-form4_1771362529.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000150749626000005/wk-form4_1771362529.xml","form_type":"4"}},{"id":902019,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":61088,"kind":"person","name":"Mutz Christopher","position":1,"cik":"0001846487","reported_name":"Mutz Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"HEAD OF RARE DISEASE"}}],"security":"Common Stock","published_at":"2026-02-17T21:08:03.000Z","date":"2026-02-14","kind":"tax_withholding","planned":true,"acquired":false,"shares":2403,"price":77.36,"value":185896.08,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 4,697 shares of restricted stock, the grant of which was previously reported on February 16, 2024."}],"balance_after":90163,"source":{"system":"sec-edgar","filing":"0001846487-26-000004","document":"wk-form4_1771362479.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000184648726000004/wk-form4_1771362479.xml","form_type":"4"}},{"id":902018,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":61088,"kind":"person","name":"Mutz Christopher","position":1,"cik":"0001846487","reported_name":"Mutz Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"HEAD OF RARE DISEASE"}}],"security":"Common Stock","published_at":"2026-02-17T21:08:03.000Z","date":"2026-02-12","kind":"sale","planned":true,"acquired":false,"shares":7032,"price":76.55,"value":538299.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 16, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The shares were sold in multiple trades at prices ranging from $75.43 to $76.92. The price reported above reflects the weighted average sales price."}],"balance_after":92566,"source":{"system":"sec-edgar","filing":"0001846487-26-000004","document":"wk-form4_1771362479.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000184648726000004/wk-form4_1771362479.xml","form_type":"4"}},{"id":902017,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":61088,"kind":"person","name":"Mutz Christopher","position":1,"cik":"0001846487","reported_name":"Mutz Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"HEAD OF RARE DISEASE"}}],"security":"Common Stock","published_at":"2026-02-17T21:08:03.000Z","date":"2026-02-12","kind":"tax_withholding","planned":true,"acquired":false,"shares":3173,"price":76.7,"value":243369.1,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 6,202 shares of restricted stock, the grant of which was previously reported on February 18, 2025."}],"balance_after":99598,"source":{"system":"sec-edgar","filing":"0001846487-26-000004","document":"wk-form4_1771362479.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000184648726000004/wk-form4_1771362479.xml","form_type":"4"}},{"id":902016,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":19644,"kind":"person","name":"Lalwani Nikhil","position":1,"cik":"0001822629","reported_name":"Lalwani Nikhil","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT & CEO"}}],"security":"Common Stock","published_at":"2026-02-17T21:07:19.000Z","date":"2026-02-14","kind":"tax_withholding","planned":false,"acquired":false,"shares":10298,"price":77.36,"value":796653.28,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 20,132 shares of restricted stock, the grant of which was previously reported on February 16, 2024."}],"balance_after":358574,"source":{"system":"sec-edgar","filing":"0001822629-26-000004","document":"wk-form4_1771362436.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000182262926000004/wk-form4_1771362436.xml","form_type":"4"}},{"id":902015,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":19644,"kind":"person","name":"Lalwani Nikhil","position":1,"cik":"0001822629","reported_name":"Lalwani Nikhil","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT & CEO"}}],"security":"Common Stock","published_at":"2026-02-17T21:07:19.000Z","date":"2026-02-12","kind":"tax_withholding","planned":false,"acquired":false,"shares":11688,"price":76.7,"value":896469.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 22,849 shares of restricted stock, the grant of which was previously reported on February 18, 2025."}],"balance_after":368872,"source":{"system":"sec-edgar","filing":"0001822629-26-000004","document":"wk-form4_1771362436.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000182262926000004/wk-form4_1771362436.xml","form_type":"4"}},{"id":902012,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":24759,"kind":"person","name":"Gutwerg Ori","position":1,"cik":"0001846478","reported_name":"Gutwerg Ori","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, GENERICS"}}],"security":"Common Stock","published_at":"2026-02-17T21:06:35.000Z","date":"2026-02-14","kind":"tax_withholding","planned":false,"acquired":false,"shares":1888,"price":77.36,"value":146055.68,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 3,691 shares of restricted stock, the grant of which was previously reported on February 16, 2024."}],"balance_after":76094,"source":{"system":"sec-edgar","filing":"0001846478-26-000004","document":"wk-form4_1771362392.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000184647826000004/wk-form4_1771362392.xml","form_type":"4"}},{"id":902011,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":24759,"kind":"person","name":"Gutwerg Ori","position":1,"cik":"0001846478","reported_name":"Gutwerg Ori","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, GENERICS"}}],"security":"Common Stock","published_at":"2026-02-17T21:06:35.000Z","date":"2026-02-12","kind":"tax_withholding","planned":false,"acquired":false,"shares":1775,"price":76.7,"value":136142.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 3,917 shares of restricted stock, the grant of which was previously reported on February 18, 2025."}],"balance_after":77982,"source":{"system":"sec-edgar","filing":"0001846478-26-000004","document":"wk-form4_1771362392.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000184647826000004/wk-form4_1771362392.xml","form_type":"4"}},{"id":902014,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":64059,"kind":"person","name":"Gassert Chad","position":1,"cik":"0001871002","reported_name":"Gassert Chad","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP - CORP. DEV. & STRATEGY"}}],"security":"Common Stock","published_at":"2026-02-17T21:05:51.000Z","date":"2026-02-14","kind":"tax_withholding","planned":false,"acquired":false,"shares":1717,"price":77.36,"value":132827.12,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 3,355 shares of restricted stock, the grant of which was previously reported on February 16, 2024."}],"balance_after":66021,"source":{"system":"sec-edgar","filing":"0001871002-26-000004","document":"wk-form4_1771362348.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000187100226000004/wk-form4_1771362348.xml","form_type":"4"}},{"id":902013,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":64059,"kind":"person","name":"Gassert Chad","position":1,"cik":"0001871002","reported_name":"Gassert Chad","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP - CORP. DEV. & STRATEGY"}}],"security":"Common Stock","published_at":"2026-02-17T21:05:51.000Z","date":"2026-02-12","kind":"tax_withholding","planned":false,"acquired":false,"shares":1608,"price":76.7,"value":123333.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 3,590 shares of restricted stock, the grant of which was previously reported on February 18, 2025."}],"balance_after":67738,"source":{"system":"sec-edgar","filing":"0001871002-26-000004","document":"wk-form4_1771362348.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000187100226000004/wk-form4_1771362348.xml","form_type":"4"}},{"id":902010,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":61838,"kind":"person","name":"Davis Krista","position":1,"cik":"0001946439","reported_name":"Davis Krista","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CHIEF HR OFFICER"}}],"security":"Common Stock","published_at":"2026-02-17T21:05:03.000Z","date":"2026-02-14","kind":"tax_withholding","planned":false,"acquired":false,"shares":1290,"price":77.36,"value":99794.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 3,020 shares of restricted stock, the grant of which was previously reported on February 16, 2024."}],"balance_after":53077,"source":{"system":"sec-edgar","filing":"0001946439-26-000004","document":"wk-form4_1771362300.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000194643926000004/wk-form4_1771362300.xml","form_type":"4"}},{"id":902009,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":61838,"kind":"person","name":"Davis Krista","position":1,"cik":"0001946439","reported_name":"Davis Krista","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CHIEF HR OFFICER"}}],"security":"Common Stock","published_at":"2026-02-17T21:05:03.000Z","date":"2026-02-12","kind":"tax_withholding","planned":false,"acquired":false,"shares":1180,"price":76.7,"value":90506.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 3,264 shares of restricted stock, the grant of which was previously reported on February 18, 2025."}],"balance_after":54367,"source":{"system":"sec-edgar","filing":"0001946439-26-000004","document":"wk-form4_1771362300.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000194643926000004/wk-form4_1771362300.xml","form_type":"4"}},{"id":902006,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":23803,"kind":"person","name":"Cook Meredith","position":1,"cik":"0001938861","reported_name":"Cook Meredith","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SR. VP, GENERAL COUNSEL & SEC."}}],"security":"Common Stock","published_at":"2026-02-17T21:04:20.000Z","date":"2026-02-14","kind":"tax_withholding","planned":true,"acquired":false,"shares":1779,"price":77.36,"value":137623.44,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 3,691 shares of restricted stock, the grant of which was previously reported on February 16, 2024."}],"balance_after":67550,"source":{"system":"sec-edgar","filing":"0001938861-26-000006","document":"wk-form4_1771362255.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000193886126000006/wk-form4_1771362255.xml","form_type":"4"}},{"id":902005,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":23803,"kind":"person","name":"Cook Meredith","position":1,"cik":"0001938861","reported_name":"Cook Meredith","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SR. VP, GENERAL COUNSEL & SEC."}}],"security":"Common Stock","published_at":"2026-02-17T21:04:20.000Z","date":"2026-02-13","kind":"sale","planned":true,"acquired":false,"shares":500,"price":76.8,"value":38400.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2025."}],"balance_after":69329,"source":{"system":"sec-edgar","filing":"0001938861-26-000006","document":"wk-form4_1771362255.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000193886126000006/wk-form4_1771362255.xml","form_type":"4"}},{"id":902004,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":23803,"kind":"person","name":"Cook Meredith","position":1,"cik":"0001938861","reported_name":"Cook Meredith","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SR. VP, GENERAL COUNSEL & SEC."}}],"security":"Common Stock","published_at":"2026-02-17T21:04:20.000Z","date":"2026-02-12","kind":"tax_withholding","planned":true,"acquired":false,"shares":1534,"price":76.7,"value":117657.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 4,243 shares of restricted stock, the grant of which was previously reported on February 18, 2025."}],"balance_after":69829,"source":{"system":"sec-edgar","filing":"0001938861-26-000006","document":"wk-form4_1771362255.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000193886126000006/wk-form4_1771362255.xml","form_type":"4"}},{"id":902008,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":18119,"kind":"person","name":"CAREY STEPHEN P.","position":1,"cik":"0001674236","reported_name":"CAREY STEPHEN P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & CFO"}}],"security":"Common Stock","published_at":"2026-02-17T21:03:27.000Z","date":"2026-02-14","kind":"tax_withholding","planned":false,"acquired":false,"shares":2448,"price":77.36,"value":189377.28,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 5,368 shares of restricted stock, the grant of which was previously reported on February 16, 2024."}],"balance_after":170083,"source":{"system":"sec-edgar","filing":"0001674236-26-000004","document":"wk-form4_1771362205.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000167423626000004/wk-form4_1771362205.xml","form_type":"4"}},{"id":902007,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":18119,"kind":"person","name":"CAREY STEPHEN P.","position":1,"cik":"0001674236","reported_name":"CAREY STEPHEN P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & CFO"}}],"security":"Common Stock","published_at":"2026-02-17T21:03:27.000Z","date":"2026-02-12","kind":"tax_withholding","planned":false,"acquired":false,"shares":2829,"price":76.7,"value":216984.3,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 6,202 shares of restricted stock, the grant of which was previously reported on February 18, 2025."}],"balance_after":172531,"source":{"system":"sec-edgar","filing":"0001674236-26-000004","document":"wk-form4_1771362205.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000167423626000004/wk-form4_1771362205.xml","form_type":"4"}},{"id":905866,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":18119,"kind":"person","name":"CAREY STEPHEN P.","position":1,"cik":"0001674236","reported_name":"CAREY STEPHEN P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & CFO"}}],"security":"Common Stock","published_at":"2026-02-13T21:13:54.000Z","date":"2026-02-11","kind":"tax_withholding","planned":false,"acquired":false,"shares":5503,"price":76.25,"value":419603.75,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 16,210 performance stock units, the grant of which was previously reported on April 6, 2023."}],"balance_after":175360,"source":{"system":"sec-edgar","filing":"0001674236-26-000002","document":"wk-form4_1771017231.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000167423626000002/wk-form4_1771017231.xml","form_type":"4"}},{"id":905865,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":23803,"kind":"person","name":"Cook Meredith","position":1,"cik":"0001938861","reported_name":"Cook Meredith","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SR. VP, GENERAL COUNSEL & SEC."}}],"security":"Common Stock","published_at":"2026-02-13T21:13:17.000Z","date":"2026-02-11","kind":"tax_withholding","planned":false,"acquired":false,"shares":3011,"price":76.25,"value":229588.75,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 8,104 performance stock units, the grant of which was previously reported on April 6, 2023."}],"balance_after":71363,"source":{"system":"sec-edgar","filing":"0001938861-26-000004","document":"wk-form4_1771017195.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000193886126000004/wk-form4_1771017195.xml","form_type":"4"}},{"id":905863,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":61838,"kind":"person","name":"Davis Krista","position":1,"cik":"0001946439","reported_name":"Davis Krista","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CHIEF HR OFFICER"}}],"security":"Common Stock","published_at":"2026-02-13T21:12:43.000Z","date":"2026-02-11","kind":"tax_withholding","planned":false,"acquired":false,"shares":3017,"price":76.25,"value":230046.25,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 8,104 performance stock units, the grant of which was previously reported on April 6, 2023."}],"balance_after":55547,"source":{"system":"sec-edgar","filing":"0001946439-26-000002","document":"wk-form4_1771017161.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000194643926000002/wk-form4_1771017161.xml","form_type":"4"}},{"id":905864,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":64059,"kind":"person","name":"Gassert Chad","position":1,"cik":"0001871002","reported_name":"Gassert Chad","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP - CORP. DEV. & STRATEGY"}}],"security":"Common Stock","published_at":"2026-02-13T21:12:08.000Z","date":"2026-02-11","kind":"tax_withholding","planned":false,"acquired":false,"shares":4269,"price":76.25,"value":325511.25,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 11,578 performance stock units, the grant of which was previously reported on April 6, 2023."}],"balance_after":69346,"source":{"system":"sec-edgar","filing":"0001871002-26-000002","document":"wk-form4_1771017125.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000187100226000002/wk-form4_1771017125.xml","form_type":"4"}},{"id":905862,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":24759,"kind":"person","name":"Gutwerg Ori","position":1,"cik":"0001846478","reported_name":"Gutwerg Ori","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, GENERICS"}}],"security":"Common Stock","published_at":"2026-02-13T21:11:20.000Z","date":"2026-02-11","kind":"tax_withholding","planned":false,"acquired":false,"shares":4267,"price":76.25,"value":325358.75,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 11,578 performance stock units, the grant of which was previously reported on April 6, 2023."}],"balance_after":79757,"source":{"system":"sec-edgar","filing":"0001846478-26-000002","document":"wk-form4_1771017077.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000184647826000002/wk-form4_1771017077.xml","form_type":"4"}},{"id":905861,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":19644,"kind":"person","name":"Lalwani Nikhil","position":1,"cik":"0001822629","reported_name":"Lalwani Nikhil","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT & CEO"}}],"security":"Common Stock","published_at":"2026-02-13T21:09:48.000Z","date":"2026-02-11","kind":"tax_withholding","planned":false,"acquired":false,"shares":30659,"price":76.25,"value":2337748.75,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 63,686 performance stock units, the grant of which was previously reported on April 6, 2023."}],"balance_after":380560,"source":{"system":"sec-edgar","filing":"0001822629-26-000002","document":"wk-form4_1771016985.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000182262926000002/wk-form4_1771016985.xml","form_type":"4"}},{"id":905860,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":61088,"kind":"person","name":"Mutz Christopher","position":1,"cik":"0001846487","reported_name":"Mutz Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"HEAD OF RARE DISEASE"}}],"security":"Common Stock","published_at":"2026-02-13T21:08:56.000Z","date":"2026-02-11","kind":"tax_withholding","planned":false,"acquired":false,"shares":4546,"price":76.25,"value":346632.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 11,578 performance stock units, the grant of which was previously reported on April 6, 2023."}],"balance_after":102771,"source":{"system":"sec-edgar","filing":"0001846487-26-000002","document":"wk-form4_1771016933.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000184648726000002/wk-form4_1771016933.xml","form_type":"4"}},{"id":905859,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":47769,"kind":"person","name":"Rowland Thomas Andrew","position":1,"cik":"0001507496","reported_name":"Rowland Thomas Andrew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, HEAD - ESTABLISHED BRANDS"}}],"security":"Common Stock","published_at":"2026-02-13T21:07:51.000Z","date":"2026-02-11","kind":"tax_withholding","planned":false,"acquired":false,"shares":1762,"price":76.25,"value":134352.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 5,788 performance stock units, the grant of which was previously reported."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 128 shares of ANI Pharmaceuticals, Inc. Common Stock that were acquired under the ANI Pharmaceuticals, Inc. Employee Stock Purchase Plan in transactions that were exempt under Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":39160,"source":{"system":"sec-edgar","filing":"0001507496-26-000003","document":"wk-form4_1771016868.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000150749626000003/wk-form4_1771016868.xml","form_type":"4"}},{"id":905858,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":64060,"kind":"person","name":"Shanmugam Muthusamy","position":1,"cik":"0001870913","reported_name":"Shanmugam Muthusamy","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"HEAD OF R&D, COO-NOVITIUM OPS"}}],"security":"Common Stock","published_at":"2026-02-13T21:06:29.000Z","date":"2026-02-11","kind":"tax_withholding","planned":false,"acquired":false,"shares":2898,"price":76.25,"value":220972.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 11,578 performance stock units, the grant of which was previously reported on April 6, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 250 shares of ANI Pharmaceuticals, Inc. Common Stock that were acquired under the ANI Pharmaceuticals, Inc. Employee Stock Purchase Plan in transactions that were exempt under Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":89940,"source":{"system":"sec-edgar","filing":"0001870913-26-000002","document":"wk-form4_1771016786.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000187091326000002/wk-form4_1771016786.xml","form_type":"4"}},{"id":939561,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":23803,"kind":"person","name":"Cook Meredith","position":1,"cik":"0001938861","reported_name":"Cook Meredith","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SR. VP, GENERAL COUNSEL & SEC."}}],"security":"Common Stock","published_at":"2026-01-14T23:14:18.000Z","date":"2026-01-13","kind":"sale","planned":true,"acquired":false,"shares":500,"price":84.33,"value":42165.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2025."}],"balance_after":74374,"source":{"system":"sec-edgar","filing":"0001938861-26-000002","document":"wk-form4_1768432456.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000193886126000002/wk-form4_1768432456.xml","form_type":"4"}}],"next_cursor":"2026-01-14T23:14:18.000000Z,939561"}